OrthoPediatrics Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KIDS research report →
Companywww.orthopediatrics.com
OrthoPediatrics Corp. , a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
- CEO
- David R. Bailey
- IPO
- 2017
- Employees
- 562
- HQ
- Warsaw, IN, US
Price Chart
Valuation
- Market Cap
- $475.17M
- P/E
- -11.04
- P/S
- 1.95
- P/B
- 1.29
- EV/EBITDA
- -47.56
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 73.07%
- Op Margin
- -12.07%
- Net Margin
- -16.31%
- ROE
- -11.42%
- ROIC
- -6.41%
Growth & Income
- Revenue
- $236.35M · 15.45%
- Net Income
- $-39,648,000 · -4.83%
- EPS
- $-1.69 · -3.05%
- Op Income
- $-28,999,000
- FCF YoY
- 61.36%
Performance & Tape
- 52W High
- $23.70
- 52W Low
- $14.42
- 50D MA
- $16.64
- 200D MA
- $17.81
- Beta
- 0.99
- Avg Volume
- 176.02K
Get TickerSpark's AI analysis on KIDS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 13, 26 | Gerritzen Daniel J | other | 2,479 |
| Mar 15, 26 | Hauser Joseph W | other | 65,700 |
| Mar 16, 26 | Hauser Joseph W | sell | 8,596 |
| Mar 15, 26 | Hite Fred | other | 77,405 |
| Mar 16, 26 | Hite Fred | sell | 12,993 |
| Mar 16, 26 | Bailey David R | sell | 19,535 |
| Mar 15, 26 | Odle Gregory A | other | 47,380 |
| Mar 16, 26 | Odle Gregory A | sell | 8,433 |
| Mar 15, 26 | Gerritzen Daniel J | other | 47,380 |
| Mar 16, 26 | Gerritzen Daniel J | sell | 8,614 |
Our KIDS Coverage
We haven't published any research on KIDS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KIDS Report →